Isolated Epidermolytic Acanthoma in a Renal Transplant Recipient by Yang, Ji-Hye et al.
Vol. 23, No. 3, 2011 415
Received May 31, 2010, Revised July 14, 2010, Accepted for 
publication July 14, 2010
Corresponding author: Mi-Woo Lee, M.D., Department of Dermatology,
Asan Medical Center, University of Ulsan College of Medicine, 388-1 
Pungnap-dong, Songpa-gu, Seoul 138-736, Korea. Tel: 82-2-3010- 
3460, Fax: 82-2-486-7831, E-mail: miumiu@amc.seoul.kr
This is an Open Access article distributed under the terms of the 
Creative Commons Attribution Non-Commercial License (http:// 
creativecommons.org/licenses/by-nc/3.0) which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
Ann Dermatol Vol. 23, No. 3, 2011 DOI: 10.5021/ad.2011.23.3.415
LETTER TO THE EDITOR
Fig. 1. A solitary, brown papule, measured 1 cm in diameter, 
with a verrucous surface on the scrotum.
Isolated Epidermolytic Acanthoma in a Renal Transplant 
Recipient
Ji-Hye Yang, M.D., Jae-Kyung Kim, M.D., Chong-Hyun Won, M.D., Sung-Eun Chang, M.D., Mi-Woo 
Lee, M.D., Jee-Ho Choi, M.D., Kee-Chan Moon, M.D.
Department of Dermatology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
Dear Editor:
Epidermolytic acanthoma (EA) was first reported in 1970 
when six patients with solitary tumors clinically resembled 
warts were observed. Histologically these tumors showed 
epidermolytic hyperkeratosis (EH) without features of 
other epidermal tumors
1. The exact etiology of EA remains 
unknown, but immunosuppression is thought to be 
associated with EA although case report is lacking.
A 64-year-old man presented with a solitary papule on his 
scrotum. The lesion first appeared 7 years earlier and had 
gradually grown over time, but had not triggered 
symptoms such as itching or pain. This patient had no 
history of similar skin lesions. He had received a kidney 
transplant 7 years previously, and noted the scrotal lesion 
occurred immediately after starting an immunosuppressive 
regimen, consisted of tacrolimus (1 mg/day), azathioprine 
(50 mg/day), and deflazacort (6 mg/day). In addition, this 
patient also had type 2 diabetes and hypertension, both of 
which were controlled by medication. There was no 
family history of skin disease.
Physical examination showed a solitary, brownish, 
verrucous, and keratotic papule, 1 cm in diameter, on the 
left side of the scrotum (Fig. 1). Histologic examination of 
a shave biopsy specimen of the lesion showed 
orthokeratotic hyperkeratosis, papillomatosis, and acan-
thosis. Hypergranulosis was also noted, and the cells of 
the granular and upper spinous layers contained 
numerous, large, clear, perinuclear space with basophilic 
keratohyaline granules and eosinophilic materials (Fig. 2). 
As a result of these clinical and histological findings, the 
patient was diagnosed with isolated EA. The scrotal lesion 
resolved after ablative CO2 laser treatment, with no 
evidence of recurrence during a 1-year follow-up period.
EA is a solitary tumor that histologically shows EH without 
features of other epidermal tumors. EA is considered to be 
an acquired benign tumor, typically occurs in middle-aged 
adults. The lesions are characteristically brownish papules 
less than 1 cm in diameter with a verrucous surface. EA 
can be classified into solitary and disseminated subtypes, 
called isolated epidermolytic acanthoma (IEA) and 
disseminated epidermolytic acanthoma (DEA), respec-
tively. Isolated lesions may occur anywhere on the body, 
but the disseminated subtype usually occurs on the back 
and the genitoscrotal area.JH Yang, et al
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Fig. 2. Histologic examination of the scrotal lesion showing epidermolytic hyperkeratosis: vacuolar degeneration, increased 
keratohyaline-like bodies, hypergranulosis and compact hyperkeratosis (A: H&E, ×40, B: H&E, ×400).
EA is characterized histologically by EH, which consists of 
random-sized clear spaces around the nuclei in the 
stratum spinosum and granulosum, reticulated, lightly-stain-
ing material forming indistinct cellular boundaries, a 
markedly thickened granular zone containing an 
increased number of small and large, irregularly shaped 
basophilic keratohyaline-like bodies, and compact 
hyperkeratosis
2. EH may be congenital or acquired. 
Congenital EH includes bullous congenital ichthyosiform 
erythroderma, systemized epidermal nevus, and heredi-
tary palmoplantar keratosis, whereas acquired EH include 
IEA and DEA. 
The etiology of EA remains unknown and the differences 
between IEA and DEA in the pathogenesis are also 
unclear. Mutations in the keratin 1 and 10 genes have 
been observed in IEA
3. EA may also be induced by 
exogenous factors, such as viruses or trauma. Human 
papillomavirus (HPV) was thought to be a cause of EA, 
because of the wart-like appearance, but these lesions 
have not been found to contain HPV DNA
4. Immuno-
suppression has been known to be associated with the 
pathogenesis of DEA. Immunosuppression could inhibit 
immune surveillance, preventing abnormal keratinocyte 
clones from being recognized or removed. Alternatively, 
immunosuppression may allow latent abnormal keratino-
cyte clones to proliferate. To date, DEA with disseminated 
superficial porokeratosis and verruca vulgaris has been 
observed in a kidney transplant patient
5, and DEA has also 
been observed after PUVA
6. Although our patient had a 
solitary lesion and the possibility of coincidental occu-
rrence of IEA may exist, this case suggests that IEA could 
be associated with immunosuppression, because the skin 
lesion had appeared immediately after commencing 
immunosuppressive treatment. Further case reports and 
studies are needed to elucidate the relationship between 
immunosuppression and EA.
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